Parallel Fluidics
Assembly Line
Parallel Fluidics Secures $7M Seed Round to Accelerate Microfluidic Development for the Next Generation of Life Science Tools
Parallel Fluidics, the fastest microfluidic device manufacturer in the world, announced the close of its $7M seed round, led by J2 Ventures with participation from 8VC and Praxis. The funding will help drive the growth of the company’s on-demand design and manufacturing platform, expand its hardware and software solutions, and commercialize its new product, MV-2.
Parallel Fluidics’ hardware library offers an array of off-the-shelf hardware solutions to solve engineering challenges in microfluidics, reducing the cost and time for customers to develop new products. The MV-2 is Parallel’s latest addition, an innovative microvalve that enables products to work at the point-of-care, like a doctor’s office, clinic, or hospital, instead of only in laboratory environments. Overture Life, an exciting life science startup simplifying in-vitro fertilization procedures, is using the MV-2 to control flow in their next-generation system.
Parallel Fluidics Announced $1.8M in Funding to Lower the Barrier to Entry for Microfluidic Development
Parallel Fluidics, a Boston-based digital manufacturer of microfluidic devices, is proud to announce it raised a $1.8 million round of financing from a syndicate of leading investors, founders, and technologists. This brings the company’s total funding to $2 million since its founding in 2020, including funding from the National Science Foundation. The company says it will use the funding to hire new employees, in particular manufacturing and mechanical engineers, and further develop its capabilities and capacity.
Parallel Fluidics was founded in 2020 by Josh Gomes, a veteran of the organ-on-chip industry, and Andy Harris, a software engineer who previously built automated orchestration systems at Uber. The pair won a $225k SBIR grant from the National Science Foundation, with a plan to reduce the friction pervasive in the development process of new microfluidic products. Parallel now offers the industry’s fastest turnaround time for prototype devices, cutting the industry-standard turnaround time of 3-4 weeks down to just two days.